Global Disease Control and Prevention Vaccine Market Insights, Forecast to 2025

Choose Licence

Vaccines are biological entity used to activate acquired immunity to control or prevent particular disease or a group of disease. Immunization is carried out in infants as well as in adults. Vaccination against various bacterial and viral diseases is an integral part of infectious disease control world-wide. 
The global Disease Control and Prevention Vaccine market is valued at 41100 million US$ in 2018 and will reach 102500 million US$ by the end of 2025, growing at a CAGR of 12.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Disease Control and Prevention Vaccine market based on company, product type, end user and key regions.

This report studies the global market size of Disease Control and Prevention Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Disease Control and Prevention Vaccine in these regions.
This research report categorizes the global Disease Control and Prevention Vaccine market by top players/brands, region, type and end user. This report also studies the global Disease Control and Prevention Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    GSK
    Merck & Co., Inc
    Pfizer
    Sanofi
    AstraZeneca PLC
    Sinovac Biotech Ltd
    Astellas Pharma Inc
    Serum Institute of India Pvt. Ltd
    Daiichi Sankyo

Market size by Product
    Live-Attenuated
    Inactivated
    Recombinant Sub Unit and Toxoid
Market size by End User
    Pediatric Vaccine
    Adult Vaccine

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Disease Control and Prevention Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Disease Control and Prevention Vaccine market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Disease Control and Prevention Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Disease Control and Prevention Vaccine submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Disease Control and Prevention Vaccine are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Disease Control and Prevention Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
    1.1  Disease Control and Prevention Vaccine Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Disease Control and Prevention Vaccine Market Size Growth Rate by Product
        1.4.2 Live-Attenuated
        1.4.3 Inactivated
        1.4.4 Recombinant Sub Unit and Toxoid
    1.5 Market by End User
        1.5.1 Global Disease Control and Prevention Vaccine Market Size Growth Rate by End User
        1.5.2 Pediatric Vaccine
        1.5.3 Adult Vaccine
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Disease Control and Prevention Vaccine Market Size
        2.1.1 Global Disease Control and Prevention Vaccine Revenue 2014-2025
        2.1.2 Global Disease Control and Prevention Vaccine Sales 2014-2025
    2.2 Disease Control and Prevention Vaccine Growth Rate by Regions
        2.2.1 Global Disease Control and Prevention Vaccine Sales by Regions
        2.2.2 Global Disease Control and Prevention Vaccine Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Disease Control and Prevention Vaccine Sales by Manufacturers
        3.1.1 Disease Control and Prevention Vaccine Sales by Manufacturers
        3.1.2 Disease Control and Prevention Vaccine Sales Market Share by Manufacturers
        3.1.3 Global Disease Control and Prevention Vaccine Market Concentration Ratio (CR5 and HHI)
    3.2 Disease Control and Prevention Vaccine Revenue by Manufacturers
        3.2.1 Disease Control and Prevention Vaccine Revenue by Manufacturers (2014-2019)
        3.2.2 Disease Control and Prevention Vaccine Revenue Share by Manufacturers (2014-2019)
    3.3 Disease Control and Prevention Vaccine Price by Manufacturers
    3.4 Disease Control and Prevention Vaccine Manufacturing Base Distribution, Product Types
        3.4.1 Disease Control and Prevention Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Disease Control and Prevention Vaccine Product Type
        3.4.3 Date of International Manufacturers Enter into Disease Control and Prevention Vaccine  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Disease Control and Prevention Vaccine Sales by Product
    4.2 Global Disease Control and Prevention Vaccine Revenue by Product
    4.3 Disease Control and Prevention Vaccine Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Disease Control and Prevention Vaccine Breakdown Data by End User

6 North America
    6.1 North America Disease Control and Prevention Vaccine by Countries
        6.1.1 North America Disease Control and Prevention Vaccine Sales by Countries
        6.1.2 North America Disease Control and Prevention Vaccine Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Disease Control and Prevention Vaccine by Product
    6.3 North America Disease Control and Prevention Vaccine by End User

7 Europe
    7.1 Europe Disease Control and Prevention Vaccine by Countries
        7.1.1 Europe Disease Control and Prevention Vaccine Sales by Countries
        7.1.2 Europe Disease Control and Prevention Vaccine Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Disease Control and Prevention Vaccine by Product
    7.3 Europe Disease Control and Prevention Vaccine by End User

8 Asia Pacific
    8.1 Asia Pacific Disease Control and Prevention Vaccine by Countries
        8.1.1 Asia Pacific Disease Control and Prevention Vaccine Sales by Countries
        8.1.2 Asia Pacific Disease Control and Prevention Vaccine Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Disease Control and Prevention Vaccine by Product
    8.3 Asia Pacific Disease Control and Prevention Vaccine by End User

9 Central & South America
    9.1 Central & South America Disease Control and Prevention Vaccine by Countries
        9.1.1 Central & South America Disease Control and Prevention Vaccine Sales by Countries
        9.1.2 Central & South America Disease Control and Prevention Vaccine Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Disease Control and Prevention Vaccine by Product
    9.3 Central & South America Disease Control and Prevention Vaccine by End User

10 Middle East and Africa
    10.1 Middle East and Africa Disease Control and Prevention Vaccine by Countries
        10.1.1 Middle East and Africa Disease Control and Prevention Vaccine Sales by Countries
        10.1.2 Middle East and Africa Disease Control and Prevention Vaccine Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Disease Control and Prevention Vaccine by Product
    10.3 Middle East and Africa Disease Control and Prevention Vaccine by End User

11 Company Profiles
    11.1 GSK
        11.1.1 GSK Company Details
        11.1.2 Company Business Overview
        11.1.3 GSK Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 GSK Disease Control and Prevention Vaccine Products Offered
        11.1.5 GSK Recent Development
    11.2 Merck & Co., Inc
        11.2.1 Merck & Co., Inc Company Details
        11.2.2 Company Business Overview
        11.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Merck & Co., Inc Disease Control and Prevention Vaccine Products Offered
        11.2.5 Merck & Co., Inc Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Details
        11.3.2 Company Business Overview
        11.3.3 Pfizer Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 Pfizer Disease Control and Prevention Vaccine Products Offered
        11.3.5 Pfizer Recent Development
    11.4 Sanofi
        11.4.1 Sanofi Company Details
        11.4.2 Company Business Overview
        11.4.3 Sanofi Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Sanofi Disease Control and Prevention Vaccine Products Offered
        11.4.5 Sanofi Recent Development
    11.5 AstraZeneca PLC
        11.5.1 AstraZeneca PLC Company Details
        11.5.2 Company Business Overview
        11.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 AstraZeneca PLC Disease Control and Prevention Vaccine Products Offered
        11.5.5 AstraZeneca PLC Recent Development
    11.6 Sinovac Biotech Ltd
        11.6.1 Sinovac Biotech Ltd Company Details
        11.6.2 Company Business Overview
        11.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Products Offered
        11.6.5 Sinovac Biotech Ltd Recent Development
    11.7 Astellas Pharma Inc
        11.7.1 Astellas Pharma Inc Company Details
        11.7.2 Company Business Overview
        11.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.7.4 Astellas Pharma Inc Disease Control and Prevention Vaccine Products Offered
        11.7.5 Astellas Pharma Inc Recent Development
    11.8 Serum Institute of India Pvt. Ltd
        11.8.1 Serum Institute of India Pvt. Ltd Company Details
        11.8.2 Company Business Overview
        11.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.8.4 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Products Offered
        11.8.5 Serum Institute of India Pvt. Ltd Recent Development
    11.9 Daiichi Sankyo
        11.9.1 Daiichi Sankyo Company Details
        11.9.2 Company Business Overview
        11.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.9.4 Daiichi Sankyo Disease Control and Prevention Vaccine Products Offered
        11.9.5 Daiichi Sankyo Recent Development

12 Future Forecast
    12.1 Disease Control and Prevention Vaccine Market Forecast by Regions
        12.1.1 Global Disease Control and Prevention Vaccine Sales Forecast by Regions 2019-2025
        12.1.2 Global Disease Control and Prevention Vaccine Revenue Forecast by Regions 2019-2025
    12.2 Disease Control and Prevention Vaccine Market Forecast by Product
        12.2.1 Global Disease Control and Prevention Vaccine Sales Forecast by Product 2019-2025
        12.2.2 Global Disease Control and Prevention Vaccine Revenue Forecast by Product 2019-2025
    12.3 Disease Control and Prevention Vaccine Market Forecast by End User
    12.4 North America Disease Control and Prevention Vaccine Forecast
    12.5 Europe Disease Control and Prevention Vaccine Forecast
    12.6 Asia Pacific Disease Control and Prevention Vaccine Forecast
    12.7 Central & South America Disease Control and Prevention Vaccine Forecast
    12.8 Middle East and Africa Disease Control and Prevention Vaccine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Disease Control and Prevention Vaccine Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables and Figures Figure Disease Control and Prevention Vaccine Product Picture Table Disease Control and Prevention Vaccine Market Segments Table Key Manufacturers Disease Control and Prevention Vaccine Covered Table Global Disease Control and Prevention Vaccine Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$) Figure Global Disease Control and Prevention Vaccine Sales Market Share by Product 2014-2025 Figure Live-Attenuated Product Picture Table Major Manufacturers of Live-Attenuated Figure Inactivated Product Picture Table Major Manufacturers of Inactivated Figure Recombinant Sub Unit and Toxoid Product Picture Table Major Manufacturers of Recombinant Sub Unit and Toxoid Table Global Disease Control and Prevention Vaccine Market Size Growth Rate by End User 2019-2025 (K Units) Figure Pediatric Vaccine Figure Adult Vaccine Figure Disease Control and Prevention Vaccine Report Years Considered Figure Global Disease Control and Prevention Vaccine Market Size 2014-2025 (Million US$) Figure Global Disease Control and Prevention Vaccine Sales 2014-2025 (K Units) Table Global Disease Control and Prevention Vaccine Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Disease Control and Prevention Vaccine Sales by Regions 2014-2019 (K Units) Table Global Disease Control and Prevention Vaccine Sales Market Share by Regions 2014-2019 Figure Global Disease Control and Prevention Vaccine Sales Market Share by Regions 2014-2019 Figure 2018 Global Disease Control and Prevention Vaccine Sales Market Share by Regions Table Global Disease Control and Prevention Vaccine Revenue by Regions 2014-2019 (Million US$) Table Global Disease Control and Prevention Vaccine Revenue Market Share by Regions 2014-2019 Figure Global Disease Control and Prevention Vaccine Revenue Market Share by Regions 2014-2019 Figure 2018 Global Disease Control and Prevention Vaccine Revenue Market Share by Regions Table Global Disease Control and Prevention Vaccine Sales by Manufacturers (2014-2019) (K Units) Table Global Disease Control and Prevention Vaccine Sales Share by Manufacturers (2014-2019) Figure Global Disease Control and Prevention Vaccine Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Disease Control and Prevention Vaccine Revenue by Manufacturers (2014-2019) (Million USD) Table Disease Control and Prevention Vaccine Revenue Share by Manufacturers (2014-2019) Figure Disease Control and Prevention Vaccine Value Share by Manufacturers in 2018 Table Key Manufacturers Disease Control and Prevention Vaccine Price (2014-2019) (USD/Unit) Table Disease Control and Prevention Vaccine Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Disease Control and Prevention Vaccine Product Type Table Date of International Manufacturers Enter into Disease Control and Prevention Vaccine Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Disease Control and Prevention Vaccine Sales by Product (2014-2019) (K Units) Table Global Disease Control and Prevention Vaccine Sales Share by Product (2014-2019) Figure Global Disease Control and Prevention Vaccine Sales Market Share by Product (2014-2019) Figure Global Disease Control and Prevention Vaccine Sales Market Share by Product in 2018 Table Global Disease Control and Prevention Vaccine Revenue by Product (2014-2019) (Million US$) Table Global Disease Control and Prevention Vaccine Revenue Share by Product (2014-2019) Figure Global Disease Control and Prevention Vaccine Revenue Market Share by Product (2014-2019) Figure Global Disease Control and Prevention Vaccine Revenue Market Share by Product in 2018 Table Disease Control and Prevention Vaccine Price by Product 2014-2019 (USD/Unit) Table Global Disease Control and Prevention Vaccine Sales by End User (2014-2019) (K Units) Table Global Disease Control and Prevention Vaccine Sales Share by End User (2014-2019) Figure Global Sales Disease Control and Prevention Vaccine Market Share by End User (2014-2019) Figure Global Sales Disease Control and Prevention Vaccine Market Share by End User in 2018 Figure North America Disease Control and Prevention Vaccine Sales Growth Rate 2014-2019 (K Units) Figure North America Disease Control and Prevention Vaccine Revenue Growth Rate 2014-2019 (Million US$) Table North America Disease Control and Prevention Vaccine Sales by Countries (2014-2019) (K Units) Table North America Disease Control and Prevention Vaccine Sales Market Share by Countries (2014-2019) Figure 2018 North America Disease Control and Prevention Vaccine Sales Market Share by Countries Table North America Disease Control and Prevention Vaccine Revenue by Countries (2014-2019) (Million US$) Table North America Disease Control and Prevention Vaccine Revenue Market Share by Countries (2014-2019) Figure 2018 North America Disease Control and Prevention Vaccine Revenue Market Share by Countries Figure United States Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure United States Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (K Units) Figure Canada Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Canada Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Mexico Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Table North America Disease Control and Prevention Vaccine Sales by Product (2014-2019) (K Units) Table North America Disease Control and Prevention Vaccine Sales Market Share by Product (2014-2019) Figure 2018 North America Disease Control and Prevention Vaccine Market Share by Product Table North America Disease Control and Prevention Vaccine Sales by End User (2014-2019) (K Units) Table North America Disease Control and Prevention Vaccine Sales Market Share by End User (2014-2019) Figure 2018 North America Disease Control and Prevention Vaccine Market Share by End User Figure Europe Disease Control and Prevention Vaccine Sales Growth Rate 2014-2019 (K Units) Figure Europe Disease Control and Prevention Vaccine Revenue Growth Rate 2014-2019 (Million US$) Table Europe Disease Control and Prevention Vaccine Sales by Countries (2014-2019) (K Units) Table Europe Disease Control and Prevention Vaccine Sales Market Share by Countries (2014-2019) Figure 2018 Europe Disease Control and Prevention Vaccine Sales Market Share by Countries Table Europe Disease Control and Prevention Vaccine Revenue by Countries (2014-2019) (Million US$) Table Europe Disease Control and Prevention Vaccine Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Disease Control and Prevention Vaccine Revenue Market Share by Countries Figure Germany Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Germany Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure France Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure France Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure UK Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure UK Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Italy Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Russia Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Table Europe Disease Control and Prevention Vaccine Sales by Product (2014-2019) (K Units) Table Europe Disease Control and Prevention Vaccine Sales Market Share by Product (2014-2019) Figure 2018 Europe Disease Control and Prevention Vaccine Market Share by Product Table Europe Disease Control and Prevention Vaccine Sales by End User (2014-2019) (K Units) Table Europe Disease Control and Prevention Vaccine Sales Market Share by End User (2014-2019) Figure 2018 Europe Disease Control and Prevention Vaccine Market Share by End User Figure Asia Pacific Disease Control and Prevention Vaccine Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific Disease Control and Prevention Vaccine Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Disease Control and Prevention Vaccine Sales by Countries (2014-2019) (K Units) Table Asia Pacific Disease Control and Prevention Vaccine Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Disease Control and Prevention Vaccine Sales Market Share by Countries Table Asia Pacific Disease Control and Prevention Vaccine Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Disease Control and Prevention Vaccine Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Disease Control and Prevention Vaccine Revenue Market Share by Countries Figure China Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure China Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Japan Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Korea Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure India Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure India Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Australia Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Indonesia Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Malaysia Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Philippines Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Thailand Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Vietnam Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Singapore Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Disease Control and Prevention Vaccine Sales by Product (2014-2019) (K Units) Table Asia Pacific Disease Control and Prevention Vaccine Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Disease Control and Prevention Vaccine Market Share by Product Table Asia Pacific Disease Control and Prevention Vaccine Sales by End User (2014-2019) (K Units) Table Asia Pacific Disease Control and Prevention Vaccine Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Disease Control and Prevention Vaccine Market Share by End User Figure Central & South America Disease Control and Prevention Vaccine Sales Growth Rate 2014-2019 (K Units) Figure Central & South America Disease Control and Prevention Vaccine Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Disease Control and Prevention Vaccine Sales by Countries (2014-2019) (K Units) Table Central & South America Disease Control and Prevention Vaccine Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Disease Control and Prevention Vaccine Sales Market Share by Countries Table Central & South America Disease Control and Prevention Vaccine Revenue by Countries (2014-2019) (Million US$) Table Central & South America Disease Control and Prevention Vaccine Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Disease Control and Prevention Vaccine Revenue Market Share by Countries Figure Brazil Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Brazil Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Argentina Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Disease Control and Prevention Vaccine Sales by Product (2014-2019) (K Units) Table Central & South America Disease Control and Prevention Vaccine Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Disease Control and Prevention Vaccine Market Share by Product Table Central & South America Disease Control and Prevention Vaccine Sales by End User (2014-2019) (K Units) Table Central & South America Disease Control and Prevention Vaccine Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Disease Control and Prevention Vaccine Market Share by End User Figure Middle East and Africa Disease Control and Prevention Vaccine Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa Disease Control and Prevention Vaccine Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Disease Control and Prevention Vaccine Sales by Countries (2014-2019) (K Units) Table Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by Countries Table Middle East and Africa Disease Control and Prevention Vaccine Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Countries Figure GCC Countries Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Turkey Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Egypt Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Disease Control and Prevention Vaccine Sales Growth Rate (2014-2019) (K Units) Figure South Africa Disease Control and Prevention Vaccine Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Disease Control and Prevention Vaccine Sales by Product (2014-2019) (K Units) Table Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Disease Control and Prevention Vaccine Market Share by Product Table Middle East and Africa Disease Control and Prevention Vaccine Sales by End User (2014-2019) (K Units) Table Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Disease Control and Prevention Vaccine Market Share by End User Table GSK Company Details Table GSK Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table GSK Recent Development Table Merck & Co., Inc Company Details Table Merck & Co., Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Merck & Co., Inc Recent Development Table Pfizer Company Details Table Pfizer Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Pfizer Recent Development Table Sanofi Company Details Table Sanofi Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Sanofi Recent Development Table AstraZeneca PLC Company Details Table AstraZeneca PLC Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table AstraZeneca PLC Recent Development Table Sinovac Biotech Ltd Company Details Table Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Sinovac Biotech Ltd Recent Development Table Astellas Pharma Inc Company Details Table Astellas Pharma Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Astellas Pharma Inc Recent Development Table Serum Institute of India Pvt. Ltd Company Details Table Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Serum Institute of India Pvt. Ltd Recent Development Table Daiichi Sankyo Company Details Table Daiichi Sankyo Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Daiichi Sankyo Recent Development Table Global Disease Control and Prevention Vaccine Sales Forecast by Regions 2019-2025 (K Units) Table Global Disease Control and Prevention Vaccine Sales Market Share Forecast by Regions 2019-2025 Table Global Disease Control and Prevention Vaccine Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Disease Control and Prevention Vaccine Revenue Market Share Forecast by Regions 2019-2025 Table Global Disease Control and Prevention Vaccine Sales Forecast by Product 2019-2025 (K Units) Table Global Disease Control and Prevention Vaccine Sales Market Share Forecast by Product 2019-2025 Table Global Disease Control and Prevention Vaccine Revenue Forecast by Product 2019-2025 (Million US$) Table Global Disease Control and Prevention Vaccine Revenue Market Share Forecast by Product 2019-2025 Table Global Disease Control and Prevention Vaccine Sales Forecast by End User 2019-2025 (K Units) Table Global Disease Control and Prevention Vaccine Sales Market Share Forecast by End User 2019-2025 Figure North America Disease Control and Prevention Vaccine Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America Disease Control and Prevention Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Disease Control and Prevention Vaccine Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe Disease Control and Prevention Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Disease Control and Prevention Vaccine Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific Disease Control and Prevention Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Disease Control and Prevention Vaccine Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America Disease Control and Prevention Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Disease Control and Prevention Vaccine Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa Disease Control and Prevention Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Disease Control and Prevention Vaccine Value Chain Table Disease Control and Prevention Vaccine Customers List Table Disease Control and Prevention Vaccine Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Other Reports by QY Research

Global Thin Film Drug Market Size, Status and Forecast 2019-2025

In 2018, the global Thin Film Drug market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Thin Film Drug status, future forecast, growth opportu...

Global Smart Wearable Sports Devices Market Size, Status and Forecast 2019-2025

In 2018, the global Smart Wearable Sports Devices market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Smart Wearable Sports Devices status, f...

Global Workflow Automation and Optimization Software Market Size, Status and Forecast 2019-2025

In 2018, the global Workflow Automation and Optimization Software market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Workflow Automation and...

Global Non-opioid Pain Patch Market Size, Status and Forecast 2019-2025

In 2018, the global Non-opioid Pain Patch market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Non-opioid Pain Patch status, future forecast, ...

Global IoT Solutions Market for Energy Market Size, Status and Forecast 2019-2025

In 2018, the global IoT Solutions Market for Energy market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global IoT Solutions Market for Energy statu...

New Pharmaceuticals and Healthcare Reports